Location History:
- Hov.ang.s, SE (1997)
- Hovas, SE (1989 - 1998)
Company Filing History:
3 out of 3 
1 out of 1 
1 out of 1 
Years Active: 1989-1998
Title: Innovator Anders Vahlne: Pioneering Advances in Immunology
Introduction
Anders Vahlne is a notable inventor based in Hovas, Sweden, recognized for his significant contributions to immunology through a series of innovative patents. With a total of eight patents to his name, Vahlne's work focuses on developing peptides with crucial applications in vaccination and antibody detection, particularly for HIV and HTLV-2.
Latest Patents
Vahlne's recent patents reflect his commitment to advancing medical science. One of his notable inventions is a series of peptides for use in vaccination and the induction of neutralizing antibodies. These novel peptides correspond to specific epitopes of the HIV-1 gp120 protein, demonstrating the ability to induce antibody-dependent cellular cytotoxicity against HIV. This groundbreaking development presents promising avenues for immunization against HIV infection and aims to elicit a heightened immune response to the virus.
Additionally, Vahlne has contributed to the detection of HTLV-2 through his patented peptides, which correspond to epitopes of HTLV-2 proteins. These peptides are immunologically reactive with HTLV-2-specific antibodies and possess the unique capability to differentiate between antibodies that recognize HTLV-1 and those that recognize HTLV-2. Such specificity opens possibilities for accurate assays in diagnosing HTLV-2 infections or exposures and potentially serves as a foundation for vaccine compositions against the virus.
Career Highlights
Throughout his career, Anders Vahlne has been affiliated with companies such as Syntello Vaccine Development and Virovahl. His work in these organizations has underpinned significant advancements in vaccine development and immunological research, further solidifying his standing as an influential figure in the field.
Collaborations
Collaboration has been a cornerstone of Vahlne's career, notably with colleagues Lars Rymo and Stig Jeansson. Together, they have driven innovation and facilitated research that bridges gaps in current immunological practices and methodologies.
Conclusion
In summary, Anders Vahlne is a key figure in immunology, recognized for his innovative thinking and the development of patented technologies that hold promise for improving public health. His research not only enhances our understanding of viral infections but also offers potential solutions for combating them through targeted vaccinations and detection methods. As he continues his work, Vahlne's contributions will undoubtedly shape the future of immunological science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.